Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$330,325
+$24,446 QoQ
Shares Held
665
-2.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,185
of 1,730 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $7,168,968 across 46 Biotechnology names. VRTX ranks #3 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
104,492 | $5,979,032 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
13,352 | $520,193 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
665 | $330,325 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,403 | $76,337 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
73 | $45,518 | |
| 6 | INCY |
Incyte Corp
|
315 | $35,708 | |
| 7 | RPRX |
Royalty Pharma plc
|
427 | $23,941 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
55 | $13,253 |
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $330,325 | 665 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $305,879 | 685 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $739,883 | 1,632 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $605,475 | 1,546 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $774,202 | 1,739 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $807,225 | 1,665 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $634,655 | 1,576 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $727,850 | 1,565 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $787,918 | 1,681 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $672,996 | 1,610 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $545,639 | 1,341 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $438,152 | 1,260 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $409,975 | 1,165 | Shares | Sole | 2023-12-13 | |
| 2023-03-31 | $380,289 | 1,207 | Shares | Sole | 2023-12-13 | |
| 2022-12-31 | $225,825 | 782 | Shares | Sole | 2023-12-13 | |
| 2022-09-30 | $233,948 | 808 | Shares | Sole | 2023-12-13 | |
| No filing history on record for this holder in this stock. | ||||||